Post-Vaccination Syndrome: Symptoms, Duration and the Spike Research

"Is post-vaccination syndrome real?", "how long does it last?" and "is there a test?" are among the most common questions in patient communities. This guide answers them using the spike protein and microclot research we've covered across our Science Hub, and is clear about where that research stops.

What is post-vaccination syndrome?

Post-vaccination syndrome (PVS), also called post-COVID-19 vaccine syndrome (PCVS), is a proposed name for chronic symptoms that start after COVID-19 vaccination and persist for months. It isn't a formally recognized diagnosis. Yale researchers note it remains unrecognized by medical authorities, and a 2025 Heliyon commentary argues it deserves clinical recognition.

It's separate from the recognized rare adverse events of COVID-19 vaccines, such as myocarditis and Guillain-Barré syndrome. Those have clear definitions and were confirmed in large safety studies, including a Global Vaccine Data Network cohort of 99 million people.

What are the symptoms?

Muscle twitching worries many people because they've read about ALS. Widespread twitching with normal strength is far more often benign, but any new weakness, swallowing or speech problems need prompt neurological review. Almost all of these symptoms overlap with long COVID, and many people with PVS have also had COVID-19. That makes the two hard to separate, which is also why the research below often studies them together.

What could cause it? Three lines of research

Our Science Hub has followed three lines of evidence. Each has lab or small-cohort support. None has been shown to cause PVS.

1. Spike protein that persists

Normally, spike made after vaccination is cleared within days to weeks. Several studies found it lasting longer in some people:

• Vaccine mRNA was detected in blood up to 28 days after vaccination.
• Mass spectrometry found a vaccine-specific spike fragment in half of tested samples, up to 187 days later.
• Patterson and colleagues reported S1 spike inside CD16+ monocytes for up to 245 days in people with PCVS who tested negative for prior infection.
• In the 2025 Yale preprint, some of the 42 people with PVS had spike more than 700 days after their last dose. Others with PVS had none, so spike can't explain every case.

Our guide to spike antibody vs antigen testing explains why these specialized assays differ from commercial "spike tests," which measure antibodies.

2. Spike fragments that form amyloid fibrils

Amyloid is a stacked, extremely stable protein shape. Linköping researchers found spike has amyloid-prone segments, and that neutrophil elastase cuts spike into fragments that form amyloid fibrils. Intact spike didn't. We cover this in neutrophil elastase and spike protein.

Those fibrils can affect clotting. In a 2025 Biochemistry study, Spike685 fibrils made fibrin clots resist plasmin, the clot-dissolving enzyme. Earlier, recombinant spike S1 had made fibrin harder to break down in plasma. Details are in spike protein amyloid fibrils.

The same Linköping group reported in a preprint that spike amyloid can speed up misfolding of prion protein and amyloid-beta in test tubes. That's a lab finding, not evidence of brain disease in people, as we explain in spike protein and Alzheimer's.

3. Microclots and immune changes

A 2026 proteomics study compared 14 people with post-vaccination or post-infection syndrome to 16 controls. It found amyloid-positive microclot material and altered coagulation and immune proteins. The signature only partly overlapped long COVID's. Our review of post-vaccination microclots weighs this evidence, and what microclots are covers the basics.

The Yale preprint also found immune differences: fewer effector CD4+ T cells, more TNF-alpha-producing CD8+ T cells, and more Epstein-Barr virus reactivation.

Next step

Looking for objective data on your own sample?

Our at-home amyloid fibrin test records Thioflavin T microscopy you can share with your doctor. It isn't a PVS test, but it shows one thing routine labs don't look at.

See the at-home test

How long does post-vaccination syndrome last?

There isn't a reliable answer. People report symptoms lasting months to years, and the spike findings show some biological changes can persist a long time. Others improve gradually. Yale's Akiko Iwasaki called the findings far from a final answer, and nobody can predict an individual's course yet.

Is there a test for post-vaccination syndrome?

No validated test exists. Diagnosis means ruling out other causes, the same approach used for long COVID, where routine blood tests are usually normal. What's available, and what each shows:

Our at-home amyloid test is the microclot imaging route. It uses Thioflavin T fluorescence microscopy on a finger-prick sample. It isn't a PVS test, doesn't measure spike, and isn't a diagnosis.

What helps?

There's no proven treatment. Doctors generally rule out other causes, treat specific symptoms such as POTS-type dizziness or nerve pain, and recommend pacing when exertion makes things worse. Be cautious about expensive "spike detox" protocols. Our spike persistence article explains why downstream treatments can't switch off a persistent source, and our review of nattokinase for microclots covers what enzymes do and don't do.

Where to go next

To compare testing options, read how to test for microclots. For treatments people ask about most, see plasmapheresis for long COVID and triple therapy.